Grantham, Mayo, Van Otterloo & Co (GMO)’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
33,778
+11,768
| +53% | +$3.69M | 0.03% | 223 |
|
|
2025
Q1 | $6.71M | Buy |
22,010
+4,818
| +28% | +$1.47M | 0.02% | 277 |
|
|
2024
Q4 | $5.71M | Buy |
+17,192
| New | +$5.71M | 0.02% | 293 |
|
|
2024
Q3 | – | Sell |
-38,237
| Closed | -$15.7M | – | 582 |
|
|
2024
Q2 | $15.7M | Buy |
38,237
+3,432
| +10% | +$1.41M | 0.05% | 229 |
|
|
2024
Q1 | $14.1M | Sell |
34,805
-16,760
| -33% | -$6.77M | 0.05% | 228 |
|
|
2023
Q4 | $15.8M | Sell |
51,565
-2,444
| -5% | -$749K | 0.07% | 198 |
|
|
2023
Q3 | $13.1M | Buy |
54,009
+8,635
| +19% | +$2.09M | 0.06% | 228 |
|
|
2023
Q2 | $10.9M | Buy |
+45,374
| New | +$10.9M | 0.05% | 250 |
|
|
2019
Q1 | – | Sell |
-12,500
| Closed | -$662K | – | 724 |
|
|
2018
Q4 | $662K | Hold |
12,500
| – | – | 0.01% | 396 |
|
|
2018
Q3 | $749K | Sell |
12,500
-6,800
| -35% | -$407K | 0.01% | 398 |
|
|
2018
Q2 | $830K | Buy |
19,300
+700
| +4% | +$30.1K | 0.01% | 370 |
|
|
2018
Q1 | $649K | Buy |
+18,600
| New | +$649K | ﹤0.01% | 424 |
|